The experts in radioprotective and cytoprotective science.
The F3 Team combines:
- More than four decades of diligent, dedicated research and development of Amifostine applications
- An established history of execution and performance in companies from start-ups to large publicly traded institutions
- A history of successful scientific product commercialization
- Countless years of medical practice and specialization in radiation physics, radiation oncology, medical oncology, and cancer treatment
- Deep experience in start-up and established pharmaceutical company management